Ernexa Therapeutics Inc expected to post a loss of $3.84 a share - Earnings Preview
Ernexa Therapeutics Inc <ERNA.OQ> expected to post a loss of $3.84 a share - Earnings Preview
Ernexa Therapeutics Inc ERNA.OQ ERNA.O is expected to report resultson November 5 (estimated) for the period ending September 30 2026
LSEG's mean analyst estimate for Ernexa Therapeutics Inc is for a loss of $3.84 per share.
The one available analyst rating on the shares is "buy".
The mean earnings estimate of analysts had fallen by about 56.4% in the last three months.
Wall Street's median 12-month price target for Ernexa Therapeutics Inc is $30.00, about 612.6% above its last closing price of $4.21
This summary was machine generated August 7 at 22:51 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)